(Q61934378)
Statements
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) (English)
0 references
October 2006
0 references
September 2008
0 references
44
0 references
40 year
0 references